반응 #159139

ord-994ecdef890e4613bc032db5de347626

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타all volatiles were removed in vacuo
  2. 2
    기타The crude material was used in the next step without further purification
  3. 3
    workup.DISSOLUTIONThe crude material was dissolved in DMF (0.5 mL)
  4. 4
    workup.STIRRINGThe reaction was stirred at room temperature
  5. 5
    기타After 18 hrs all volatiles were removed in vacuo
  6. 6
    기타The crude material, which was purified by RP-HPLC (eluent: water/MeCN w/0.1% TFA)

실험 절차

2-{5-[4-(6-{2-[5-(2-Methoxycarbonylamino-3-methyl-butyryl)-5-aza-spiro[2.4]hept-6-yl]-1H-imidazol-4-yl}-naphthalen-2-yl)-phenyl]-1H-imidazol-2-yl}-thiazolidine-3-carboxylic acid tert-butyl ester (49.9 mg, 0.064 mmol) was dissolved in DCM (0.33 mL) and HCl in dioxane (4M, 0.33 mL) was added and stirring at room temperature was continued. After 45 minutes, all volatiles were removed in vacuo. The crude material was used in the next step without further purification. The crude material was dissolved in DMF (0.5 mL) and DIEA (24.6 mg, 0.191 mmol) was added. A solution of 2-(L) methoxycarbonylamino-(tetrahydro-pyran-4-yl)-acetic acid (13.8 mg, 0.064 mmol), HATU (24.1 mg, 0.064 mmol) and DIEA (8.2 mg, 0.064 mmol) in DMF (0.5 mL) was added. The reaction was stirred at room temperature. After 18 hrs all volatiles were removed in vacuo. The crude material, which was purified by RP-HPLC (eluent: water/MeCN w/0.1% TFA) to yield the product (6.2 mg) as a TFA salt.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08822430B2uspto-grants-2014_09